Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

587 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma.
Gonzalez-Kozlova E, Huang HH, Jagede OA, Tuballes K, Del Valle DM, Kelly G, Patel M, Xie H, Harris J, Argueta K, Nie K, Barcessat V, Moravec R, Altreuter J, Duose DY, Kahl BS, Ansell SM, Yu J, Cerami E, Lindsay JR, Wistuba II, Kim-Schulze S, Diefenbach CS, Gnjatic S. Gonzalez-Kozlova E, et al. Among authors: ansell sm. Cancer Res Commun. 2024 Jul 1;4(7):1726-1737. doi: 10.1158/2767-9764.CRC-24-0252. Cancer Res Commun. 2024. PMID: 38934093 Free PMC article. Clinical Trial.
Exploring Gene Expression Profiles in Primary Central Nervous System Vasculitis.
Salvarani C, Paludo J, Hunder GG, Ansell SM, Giannini C, Parisi JE, Huston J 3rd, Koster MJ, Warrington KJ, Croci S, Brown RD Jr. Salvarani C, et al. Among authors: ansell sm. Ann Neurol. 2023 Jan;93(1):120-130. doi: 10.1002/ana.26537. Epub 2022 Nov 9. Ann Neurol. 2023. PMID: 36264136
Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria.
King RL, Khurana A, Mwangi R, Fama A, Ristow KM, Maurer MJ, Macon WR, Ansell SM, Bennani NN, Kudva YC, Walker RC, Watt KD, Schwab TR, Kushwaha SS, Cerhan JR, Habermann TM. King RL, et al. Among authors: ansell sm. Hemasphere. 2021 Sep 6;5(10):e640. doi: 10.1097/HS9.0000000000000640. eCollection 2021 Oct. Hemasphere. 2021. PMID: 34514344 Free PMC article.
A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
Micallef IN, Kahl BS, Maurer MJ, Dogan A, Ansell SM, Colgan JP, Geyer S, Inwards DJ, White WL, Habermann TM. Micallef IN, et al. Among authors: ansell sm. Cancer. 2006 Dec 15;107(12):2826-32. doi: 10.1002/cncr.22342. Cancer. 2006. PMID: 17099879 Free article. Clinical Trial.
Brentuximab vedotin.
Ansell SM. Ansell SM. Blood. 2014 Nov 20;124(22):3197-200. doi: 10.1182/blood-2014-06-537514. Epub 2014 Oct 7. Blood. 2014. PMID: 25293772 Free article.
Nivolumab in the Treatment of Hodgkin Lymphoma.
Ansell SM. Ansell SM. Clin Cancer Res. 2017 Apr 1;23(7):1623-1626. doi: 10.1158/1078-0432.CCR-16-1387. Epub 2016 Nov 23. Clin Cancer Res. 2017. PMID: 27881581 Review.
587 results